Low expression of SPARC in gastric cancer-associated fibroblasts leads to stemness transformation and 5-fluorouracil resistance in gastric cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Low expression of SPARC in gastric cancer-associated fibroblasts leads to stemness transformation and 5-fluorouracil resistance in gastric cancer
Authors
Keywords
-
Journal
Cancer Cell International
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-05-21
DOI
10.1186/s12935-019-0844-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Direct Interactions With Cancer-Associated Fibroblasts Lead to Enhanced Pancreatic Cancer Stem Cell Function
- (2019) Asma Begum et al. PANCREAS
- Activated gastric cancer-associated fibroblasts contribute to the malignant phenotype and 5-FU resistance via paracrine action in gastric cancer
- (2018) Yongchen Ma et al. Cancer Cell International
- Defective Replication Stress Response Is Inherently Linked to the Cancer Stem Cell Phenotype
- (2018) Daniel J. McGrail et al. Cell Reports
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Canadian Cancer Trials Group (CCTG) IND215: A phase Ib study of Selumetinib in patients with untreated advanced or metastatic NSCLC who are receiving standard chemotherapy regimens
- (2018) J. R. Goffin et al. INVESTIGATIONAL NEW DRUGS
- Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer
- (2017) E Hessmann et al. GUT
- The relationship between SPARC expression in primary tumor and metastatic lymph node of resected pancreatic cancer patients and patients' survival
- (2017) Xin-Zhe Yu et al. Hepatobiliary & Pancreatic Diseases International
- Correlation between secreted protein acidic and rich in cysteine protein expression and the prognosis of postoperative patients exhibiting esophageal squamous cell carcinoma
- (2017) Jian Wu et al. Molecular Medicine Reports
- The ‘SPARC’ of life: Analysis of the role of osteonectin/SPARC in pancreatic cancer (Review)
- (2016) MONICA K. ROSSI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Slow binding kinetics of secreted protein, acidic, rich in cysteine-VEGF interaction limit VEGF activation of VEGF receptor 2 and attenuate angiogenesis
- (2015) Marzena Cydzik et al. FASEB JOURNAL
- 5-Fluorouracil Chemotherapy of Gastric Cancer Generates Residual Cells with Properties of Cancer Stem Cells
- (2015) Zhi-Yuan Xu et al. International Journal of Biological Sciences
- SPARC Controls Melanoma Cell Plasticity through Rac1
- (2015) Edgardo Salvatierra et al. PLoS One
- Systematic review/Meta-analysis Prognostic role of SPARC expression in gastric cancer: a meta-analysis
- (2014) Zishu Wang et al. Archives of Medical Science
- Prognostic Value of SPARC Expression in Unresectable NSCLC Treated with Concurrent Chemoradiotherapy
- (2014) Neslihan Kurtul et al. Asian Pacific Journal of Cancer Prevention
- Therapeutic targeting of the mTOR-signalling pathway in cancer: benefits and limitations
- (2014) M Moschetta et al. BRITISH JOURNAL OF PHARMACOLOGY
- SPARC expression is negatively correlated with clinicopathological factors of gastric cancer and inhibits malignancy of gastric cancer cells
- (2014) JUNLING ZHANG et al. ONCOLOGY REPORTS
- Aberrant methylation of the SPARC gene promoter and its clinical implication in gastric cancer
- (2014) Zi-Yi Chen et al. Scientific Reports
- Colon Cancer Cells Escape 5FU Chemotherapy-Induced Cell Death by Entering Stemness and Quiescence Associated with the c-Yes/YAP Axis
- (2013) Y. Touil et al. CLINICAL CANCER RESEARCH
- Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity
- (2012) Appalaraju Jaggupilli et al. Clinical & Developmental Immunology
- The Role of SPARC Protein Expression in the Progress of Gastric Cancer
- (2012) Lifeng Wang et al. PATHOLOGY & ONCOLOGY RESEARCH
- Universal sample preparation method for proteome analysis
- (2009) Jacek R Wiśniewski et al. NATURE METHODS
- Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations
- (2008) J LOPICCOLO et al. DRUG RESISTANCE UPDATES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now